Previous COVID-19 infection, but not Long-COVID, is associated with increased adverse events following BNT162b2/Pfizer vaccination
Author:
Publisher
Elsevier BV
Subject
Infectious Diseases,Microbiology (medical)
Reference10 articles.
1. Reactogenicity, safety and antibody response, after one and two doses of mRNA-1273 in seronegative and seropositive healthcare workers;Tré-Hardy;J Infect,2021
2. Robust spike antibody responses and increased reactogenicity in seropositive individuals after a 1 single dose of SARS-CoV-2 mRNA vaccine;Krammer;MedRxiv,2021
3. Kings College London COVID Symptom Study. Here's what we know so far about the after effects of the Pfizer COVID vaccine. 2021. https://covid.joinzoe.com/post/covid-vaccine-pfizer-effects (accessed Feb 5, 2021).
4. Mathioudakis A.G., Ghrew M., Ustianowski A. et al. Self-reported real-world safety and reactogenicity of COVID-19 vaccines: an international vaccine-recipient survey. MedRxiv 2021; 2021.02.26.21252096. doi: 10.1101/2021.02.26.21252096.
5. Gemelli against COVID-19 post-acute care study group. persistent symptoms in patients after acute COVID-19;Carfì;JAMA,2020
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Analysis of influencing factors on long COVID in COVID-19 patients infected with omicron variant three months after discharge: a cross-sectional study;BMC Infectious Diseases;2024-01-02
2. Role of previous infection with SARS-CoV-2 in protecting against omicron reinfections and severe complications of COVID-19 compared to pre-omicron variants: a systematic review;BMC Infectious Diseases;2023-06-26
3. A systematic review of the evidence on the associations and safety of COVID-19 vaccination and post COVID-19 condition;Epidemiology and Infection;2023
4. COVID-19 vaccination in the national security system of the Russian Federation: coordination of private and public interests;Law Enforcement Review;2022-12-24
5. Hospital admission and vaccination as predictive factors of long COVID-19 symptoms;Frontiers in Medicine;2022-11-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3